We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Combined Therapy Treats Spinal Tumors

By HospiMedica International staff writers
Posted on 28 Jul 2011
A new system for the treatment of spinal tumors allows for the concurrent treatment and stabilization of the spine. More...


Developed by researchers at Johannes Gutenberg University (JGU; Mainz, Germany), the new treatment is a combination of radiofrequency (RF) ablation, which uses the heat energy of RF waves to ablate and destroy tumors, and a subsequent kyphoplasty, by which the spine is stabilized through the injection of bone cement as filler material. A single-center study involving 10 evaluable patients suffering from painful metastatic spinal tumors is expected to provide information about the efficacy of this method.

The treatment is based on the Spinal Tumor Ablation with Radiofrequency (STAR) system, developed at DFine (San Jose, CA, USA), which permits minimally invasive targeted tumor necrosis of metastatic spinal tumors. The system offers unparalleled control, and enables the physician to overcome many of the technical challenges that have limited targeted ablation in boney tissues to date. Following ablation with the STAR system, vertebrae are stabilized with ultra-high viscosity bone cement; the minimally invasive procedure generally takes about an hour.

“Due to the critical anatomy in the spine and the invasive nature of conventional surgical procedures to treat spinal metastases, we believe DFine's minimally invasive therapy that allows targeted delivery of radiofrequency energy for ablation of tumors may provide the fastest and most effective relief from the painful effects of spinal metastases, and thereby represents a significant advance in the patient's treatment,” said Prof. Andreas Kurth, MD, director of the Orthopedic Clinic at the JGU Medical Center.

“We are confident that this advanced method employed for tumor reduction and simultaneous stabilization of the spine through bone-sparing kyphoplasty will minimize the cancer patient's severe discomfort while stabilizing the vertebra,” concluded Dr. Kurth.

Related Links:
Johannes Gutenberg University
DFine



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Tourniquet System
heidi– mein Tourniquet
New
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.